Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem J J Falkenburg

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Rheumatology|December 10, 2017
Evolution of autoantibody responses in individuals at risk of rheumatoid arthritisWillem J J Falkenburg, Dirkjan van Schaardenburg
Seminars in Arthritis and Rheumatism|July 24, 2018
On the origin of rheumatoid factors: Insights from analyses of variable region sequencesWillem J J Falkenburg, Helen J von Richthofen, Theo Rispens
Medical Mycology Case Reports|November 10, 2022
Olecranon bursitis caused by <i>Scedosporium apiospermum</i> in a patient treated with CAR-T cellsWillem J J Falkenburg, Marit Jalink, Marie José Kersten, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA ResponsesWillem J J Falkenburg, Dirkjan van Schaardenburg, Pleuni Ooijevaar-de Heer, et al.
Rheumatology (Oxford, England)|February 27, 2018
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylationWillem J J Falkenburg, Ayla C Kempers, Gillian Dekkers, et al.
Rheumatology (Oxford, England)|October 5, 2017
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylationWillem J J Falkenburg, Ayla C Kempers, Gillian Dekkers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2020
Identification of Clinically and Pathophysiologically Relevant Rheumatoid Factor Epitopes by Engineered IgG TargetsWillem J J Falkenburg, Nienke Oskam, Jana Koers, et al.
Clinical Chemistry and Laboratory Medicine|February 11, 2018
Clinically relevant discrepancies between different rheumatoid factor assaysWillem J J Falkenburg, Helen J von Richthofen, Jana Koers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2016
Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted NeoepitopesWillem J J Falkenburg, Dirkjan van Schaardenburg, Pleuni Ooijevaar-de Heer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2011
Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuityWillem J J Falkenburg, J Joseph Melenhorst, Marian van de Meent, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Rheumatology|December 10, 2017
Evolution of autoantibody responses in individuals at risk of rheumatoid arthritisWillem J J Falkenburg, Dirkjan van Schaardenburg
Seminars in Arthritis and Rheumatism|July 24, 2018
On the origin of rheumatoid factors: Insights from analyses of variable region sequencesWillem J J Falkenburg, Helen J von Richthofen, Theo Rispens
Medical Mycology Case Reports|November 10, 2022
Olecranon bursitis caused by <i>Scedosporium apiospermum</i> in a patient treated with CAR-T cellsWillem J J Falkenburg, Marit Jalink, Marie José Kersten, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA ResponsesWillem J J Falkenburg, Dirkjan van Schaardenburg, Pleuni Ooijevaar-de Heer, et al.
Rheumatology (Oxford, England)|February 27, 2018
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylationWillem J J Falkenburg, Ayla C Kempers, Gillian Dekkers, et al.
Rheumatology (Oxford, England)|October 5, 2017
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylationWillem J J Falkenburg, Ayla C Kempers, Gillian Dekkers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2020
Identification of Clinically and Pathophysiologically Relevant Rheumatoid Factor Epitopes by Engineered IgG TargetsWillem J J Falkenburg, Nienke Oskam, Jana Koers, et al.
Clinical Chemistry and Laboratory Medicine|February 11, 2018
Clinically relevant discrepancies between different rheumatoid factor assaysWillem J J Falkenburg, Helen J von Richthofen, Jana Koers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2016
Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted NeoepitopesWillem J J Falkenburg, Dirkjan van Schaardenburg, Pleuni Ooijevaar-de Heer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2011
Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuityWillem J J Falkenburg, J Joseph Melenhorst, Marian van de Meent, et al.
Pageof 1